News
Eli Lilly has unveiled plans to expand its long-standing partnership with Purdue University, with the drugmaker investing up ...
AbbVie’s Emrelis (telisotuzumab vedotin-tllv) has been granted accelerated approval by the US Food and Drug Administration ...
Novo Nordisk and Septerna have announced a new partnership worth $2.2bn to develop oral small molecule drugs for type 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results